These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37459862)

  • 21. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group.
    Zhang H; Wu X; Zhang X; Chang SX; Megooni A; Donnelly ED; Ahmed MM; Griffin RJ; Welsh JS; Simone CB; Mayr NA
    Radiat Res; 2020 Dec; 194(6):665-677. PubMed ID: 33348375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probability dynamics of a repopulating tumor in case of fractionated external radiotherapy.
    Stavreva N; Stavrev P; Fallone BG
    Phys Med; 2009 Dec; 25(4):181-91. PubMed ID: 19345599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An International Consensus on the Design of Prospective Clinical-Translational Trials in Spatially Fractionated Radiation Therapy.
    Mayr NA; Snider JW; Regine WF; Mohiuddin M; Hippe DS; Peñagarícano J; Mohiuddin M; Kudrimoti MR; Zhang H; Limoli CL; Le QT; Simone CB
    Adv Radiat Oncol; 2022; 7(2):100866. PubMed ID: 35198833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional dose rate spatially-fractionated radiation therapy (SFRT) treatment response and its association with dosimetric parameters-A preclinical study in a Fischer 344 rat model.
    Rivera JN; Kierski TM; Kasoji SK; Abrantes AS; Dayton PA; Chang SX
    PLoS One; 2020; 15(6):e0229053. PubMed ID: 32569277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Technical and Clinical Implementation of LATTICE Radiation Therapy (LRT).
    Wu X; Perez NC; Zheng Y; Li X; Jiang L; Amendola BE; Xu B; Mayr NA; Lu JJ; Hatoum GF; Zhang H; Chang SX; Griffin RJ; Guha C
    Radiat Res; 2020 Dec; 194(6):737-746. PubMed ID: 33064814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined High-Dose LATTICE Radiation Therapy and Immune Checkpoint Blockade for Advanced Bulky Tumors: The Concept and a Case Report.
    Jiang L; Li X; Zhang J; Li W; Dong F; Chen C; Lin Q; Zhang C; Zheng F; Yan W; Zheng Y; Wu X; Xu B
    Front Oncol; 2020; 10():548132. PubMed ID: 33643893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response.
    Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA
    PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome.
    Lewin TD; Maini PK; Moros EG; Enderling H; Byrne HM
    Bull Math Biol; 2018 May; 80(5):1207-1235. PubMed ID: 29488054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatially fractionated radiation induces cytotoxicity and changes in gene expression in bystander and radiation adjacent murine carcinoma cells.
    Asur RS; Sharma S; Chang CW; Penagaricano J; Kommuru IM; Moros EG; Corry PM; Griffin RJ
    Radiat Res; 2012 Jun; 177(6):751-65. PubMed ID: 22559204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report.
    Massaccesi M; Boldrini L; Romano A; Rossi E; Schinzari G; Lepre E; Gambacorta MA; Valentini V
    Immunotherapy; 2021 Dec; 13(18):1457-1463. PubMed ID: 34664999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational Approach for Spatially Fractionated Radiation Therapy (SFRT) and Immunological Response in Precision Radiation Therapy.
    Castorina P; Castiglione F; Ferini G; Forte S; Martorana E
    J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined α-programmed death-1 monoclonal antibody blockade and fractionated radiation therapy reduces tumor growth in mouse EL4 lymphoma.
    Lin X; Zeng T; Xiong J; Zhang Q; Jiang P; Li X; Lin S; Xu Q; Weng H; Lai H; Gong H; Lin J; Cheng N; Tian X; Xu Y; Fang S; Jin R; Chen Z; Yang J; Morton L; Yueh B; Lin J
    Cancer Biol Ther; 2019; 20(5):666-679. PubMed ID: 30572778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy.
    Takahashi J; Nagasawa S; Doi M; Takahashi M; Narita Y; Yamamoto J; Ikemoto MJ; Iwahashi H
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy.
    Alfonso JCL; Berk L
    Radiat Oncol; 2019 May; 14(1):88. PubMed ID: 31146751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should Peak Dose Be Used to Prescribe Spatially Fractionated Radiation Therapy?-A Review of Preclinical Studies.
    Fernandez-Palomo C; Chang S; Prezado Y
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numerical simulation of normal and cancer cells' populations with fractional derivative under radiotherapy.
    Farayola MF; Shafie S; Mohd Siam F; Khan I
    Comput Methods Programs Biomed; 2020 Apr; 187():105202. PubMed ID: 31835107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiobiological basis of SBRT and SRS.
    Song CW; Kim MS; Cho LC; Dusenbery K; Sperduto PW
    Int J Clin Oncol; 2014 Aug; 19(4):570-8. PubMed ID: 24993673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications.
    Jenkins SV; Johnsrud AJ; Dings RPM; Griffin RJ
    Semin Radiat Oncol; 2024 Jul; 34(3):284-291. PubMed ID: 38880537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
    Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.